Candel Therapeutics(CADL) - 2023 Q1 - Quarterly Report

55 Additionally, the conduct of our clinical trials, preclinical studies and manufacturing activities is dependent upon the availability of clinical trial sites, CROs, CMOs, researchers and investigators, regulatory agency personnel and logistics providers, all of which may in the future be adversely affected by the COVID-19 pandemic or any future public health crisis. Any negative impact that the COVID-19 pandemic or any future public health crisis may have on enrolling or retaining patients in our clinica ...